The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
This is the first update to the original CTS communication distributed on July 6th. As previously co...